Cargando…
Different chemical proteomic approaches to identify the targets of lapatinib
The process of identifying the protein targets and off-targets of a biologically active compound is of great importance in modern drug discovery. Various chemical proteomics approaches have been established for this purpose. To compare the different approaches, and to understand which method would p...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980154/ https://www.ncbi.nlm.nih.gov/pubmed/36856014 http://dx.doi.org/10.1080/14756366.2023.2183809 |
_version_ | 1784899858207866880 |
---|---|
author | Kovačević, Tatjana Nujić, Krunoslav Cindrić, Mario Dragojević, Snježana Vinter, Adrijana Hozić, Amela Mesić, Milan |
author_facet | Kovačević, Tatjana Nujić, Krunoslav Cindrić, Mario Dragojević, Snježana Vinter, Adrijana Hozić, Amela Mesić, Milan |
author_sort | Kovačević, Tatjana |
collection | PubMed |
description | The process of identifying the protein targets and off-targets of a biologically active compound is of great importance in modern drug discovery. Various chemical proteomics approaches have been established for this purpose. To compare the different approaches, and to understand which method would provide the best results, we have chosen the EGFR inhibitor lapatinib as an example molecule. Lapatinib derivatives were designed using linkers with motifs, including amino (amidation), alkyne (click chemistry) and the diazirine group (photo-affinity). These modified lapatinib analogues were validated for their ability to inhibit EGFR activity in vitro and were shown to pull down purified recombinant EGFR protein. In all of the approaches evaluated here, we identified EGFR as the main protein target from the lysate of immortalised cell line expressing EGFR, thus validating its potential use to identify unknown protein targets. Taken together, the results reported here give insight into the cellular activities of lapatinib. |
format | Online Article Text |
id | pubmed-9980154 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-99801542023-03-03 Different chemical proteomic approaches to identify the targets of lapatinib Kovačević, Tatjana Nujić, Krunoslav Cindrić, Mario Dragojević, Snježana Vinter, Adrijana Hozić, Amela Mesić, Milan J Enzyme Inhib Med Chem Research Paper The process of identifying the protein targets and off-targets of a biologically active compound is of great importance in modern drug discovery. Various chemical proteomics approaches have been established for this purpose. To compare the different approaches, and to understand which method would provide the best results, we have chosen the EGFR inhibitor lapatinib as an example molecule. Lapatinib derivatives were designed using linkers with motifs, including amino (amidation), alkyne (click chemistry) and the diazirine group (photo-affinity). These modified lapatinib analogues were validated for their ability to inhibit EGFR activity in vitro and were shown to pull down purified recombinant EGFR protein. In all of the approaches evaluated here, we identified EGFR as the main protein target from the lysate of immortalised cell line expressing EGFR, thus validating its potential use to identify unknown protein targets. Taken together, the results reported here give insight into the cellular activities of lapatinib. Taylor & Francis 2023-03-01 /pmc/articles/PMC9980154/ /pubmed/36856014 http://dx.doi.org/10.1080/14756366.2023.2183809 Text en © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Paper Kovačević, Tatjana Nujić, Krunoslav Cindrić, Mario Dragojević, Snježana Vinter, Adrijana Hozić, Amela Mesić, Milan Different chemical proteomic approaches to identify the targets of lapatinib |
title | Different chemical proteomic approaches to identify the targets of lapatinib |
title_full | Different chemical proteomic approaches to identify the targets of lapatinib |
title_fullStr | Different chemical proteomic approaches to identify the targets of lapatinib |
title_full_unstemmed | Different chemical proteomic approaches to identify the targets of lapatinib |
title_short | Different chemical proteomic approaches to identify the targets of lapatinib |
title_sort | different chemical proteomic approaches to identify the targets of lapatinib |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980154/ https://www.ncbi.nlm.nih.gov/pubmed/36856014 http://dx.doi.org/10.1080/14756366.2023.2183809 |
work_keys_str_mv | AT kovacevictatjana differentchemicalproteomicapproachestoidentifythetargetsoflapatinib AT nujickrunoslav differentchemicalproteomicapproachestoidentifythetargetsoflapatinib AT cindricmario differentchemicalproteomicapproachestoidentifythetargetsoflapatinib AT dragojevicsnjezana differentchemicalproteomicapproachestoidentifythetargetsoflapatinib AT vinteradrijana differentchemicalproteomicapproachestoidentifythetargetsoflapatinib AT hozicamela differentchemicalproteomicapproachestoidentifythetargetsoflapatinib AT mesicmilan differentchemicalproteomicapproachestoidentifythetargetsoflapatinib |